 NEW YORK, NY, May 13, 2021 GLOBE NEWSWIRE -- Daxor Corporation NYSE MKT: DXR, the global leader in blood volume measurement technology, today announced a Q1 2021 increase in revenue of 61 in its operating division on a year-over-year basis. In addition, the sales team has recorded the opening of five new customer accounts utilizing BVA and reports a growing pipeline of additional acquisitions of Daxors BVA-100 Blood Volume Analyzer slated for Q3 2021 at major medical centers across the U.S. 